Blog

In-development HDAC inhibitors could wipe out breast, ovarian cancer stem cells – FierceBiotech


FierceBiotech

In-development HDAC inhibitors could wipe out breast, ovarian cancer stem cells
FierceBiotech
Scientists at the University of Miami have developed a genetically engineered cell line to show that HDAC inhibitors could potentially target and stamp out “stubborn reservoirs” of breast and ovarian cancer stem cells. Cancer stem cells often evade

2016-10-04 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.